Yew Chung College of Early Childhood Education offers Hong Kong's Only Government-Recognized Special Child Care Work Registration within its PGDE(ECE) Programme
HONG KONG, June 10, 2025 /PRNewswire/ -- Yew Chung College of Early Childhood Education (YCCECE) proudly announces that its Postgraduate Diploma in Education (Early Childhood Education)(PGDE(ECE)) Programme has received formal recognition from the...
Acer Reports May Revenues at NT$19.17 Billion, Up 3.1% Month-on-month
TAIPEI, June 9, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for May at NT$19.17 billion with 3.1% growth month-on-month. Consolidated revenues for year-to-May reached NT$99.18 billion with 1.4% growth YoY, while...
Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class
Duke-NUS Medical School's Class of 2025 graduates 121 medical and doctoral students, including MDs, MD-PhDs, PhDs, and masters' degrees Landmark first batch of Masters in Patient Safety and Healthcare Quality graduates, unique to Southeast Asia...
AccurEdit Therapeutics' ART001 Becomes China's First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
RMAT designation expected to expedite development; 72 weeks interim clinical trial data showing sustainable reduction of TTR over 90% with no significant adverse events. SUZHOU, China, May 29, 2025 /PRNewswire/ -- AccurEdit Therapeutics today...
Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA
SHENZHEN, China, May 29, 2025 /PRNewswire/ -- On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its independently developed...
Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq
NANJING, China, May 23, 2025 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it has received written notification from the staff of the Listing...
FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 23, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company...
Wafra Named Euromoney's Best Islamic Fund Manager for Second Consecutive Year
NEW YORK, May 21, 2025 /PRNewswire/ -- Wafra Inc. ("Wafra"), a leading global alternative investment firm headquartered in New York, announced today that its Global Sukuk Team has been named Best Islamic Fund Manager1 at the 2025 Euromoney Islamic...
Modern Dairy Wins Six Awards in Extel's 2025 Asia (ex-Japan) Executive Team Rankings
HONG KONG, May 20, 2025 /PRNewswire/ -- On May 20, the prestigious financial magazine "Extel" (formerly "Institutional Investor") officially announced the results of the "2025 Asia (ex-Japan) Executive Team-SMID" rankings. The survey assessed and...
Pulnovo Medical Welcomes EQT as a New Investor Following CE-MDR Approval, with Continued Support from Qiming Venture Partners
HONG KONG, May 20, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has received new investment from EQT Group, a top-tier global private equity firm, as a...